Kilitch Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
For the six months, sales was INR 641.5 million compared to INR 431.95 million a year ago. Revenue was INR 653.61 million compared to INR 444.17 million a year ago. Net income was INR 45.14 million compared to INR 33.44 million a year ago. Basic earnings per share from continuing operations was INR 2.9 compared to INR 2.15 a year ago. Diluted earnings per share from continuing operations was INR 2.9 compared to INR 2.15 a year ago.